Top Healthcare Press Releases You Shouldn't Miss This Week

Weekly Recap: Must-See Health Press Releases



In the ever-evolving landscape of healthcare, keeping abreast of the latest developments can be a challenge. This week, PR Newswire released a series of press releases that are essential for healthcare journalists, professionals, and consumers alike. Here's a recap of some significant announcements that you should not overlook:

1. Lilly's Acquisition of Verve Therapeutics


Lilly is set to acquire Verve Therapeutics, focusing on pioneering one-time treatments for individuals at high cardiovascular risk. Dr. Sekar Kathiresan of Verve emphasized their mutual goal of transforming cardiovascular disease management from chronic care to a future where a single dose could suffice. This collaboration aims to leverage Lilly's extensive global capabilities to expedite the development of transformative medicines.

2. Shasqi's Landmark Study in Cancer Research


In a groundbreaking study published in Clinical Cancer Research, Shasqi has introduced a pre-targeting technology known as Click Activated Protodrugs Against Cancer (CAPAC®). This innovative approach uses click chemistry to release high concentrations of cancer-fighting drugs directly at tumor sites, sparing healthy tissues and paving the way for new targeted therapies.

3. Visby Medical's $65 Million Financing Round


Visby Medical raised up to $65 million to accelerate the launch of its groundbreaking at-home sexually transmitted infections (STI) test. This test is the first single-use disposable PCR diagnostic, providing results in just 30 minutes via a smartphone app. Following positive results, users can seamlessly connect with telemedicine providers, enhancing both accessibility and privacy in healthcare delivery. The product is expected to become available in July 2025 through major direct-to-consumer channels.

4. FDA Approves Neuspera Medical's iSNM System


The FDA has granted approval for Neuspera Medical's integrated sacral neuromodulation (iSNM) system, designed to treat urinary urge incontinence. Dr. Howard Goldman from the Cleveland Clinic stated that this new system represents a major advancement in treatment options, alleviating the concerns regarding implanted batteries and associated surgeries that have historically burdened patients.

5. Arbonne's Innovative Hair Care Collection


Arbonne has unveiled a new plant-powered hair care collection formulated with scalp science in mind. Ingredients like Green Coffee Oil and Pea Peptide drive this collection’s effectiveness, while remaining vegan and cruelty-free. Each product falls in line with the company's commitment to excluding over 2,000 harmful ingredients, fostering a clean beauty approach.

6. Collaboration Between Ratio Therapeutics and Nusano


Ratio Therapeutics and Nusano have entered into a long-term agreement to enhance the supply of cancer radiopharmaceuticals. This partnership showcases their shared commitment to innovation within the radiopharmaceutical field, capitalizing on Ratio's new manufacturing facility in Utah to streamline operations and logistics.

7. CSL's Prophylactic Treatment for Hereditary Angioedema


The FDA has approved CSL's ANDEMBRY® (garadacimab-gxii), the first monoclonal antibody specifically targeting factor XIIa for the prophylactic treatment of hereditary angioedema. This breakthrough therapy promises long-term control for patients suffering from this life-threatening condition, significantly advancing treatment options available today.

8. Affordable Obesity Care Collaboration


The Mark Cuban Cost Plus Drug Company has joined forces with 9amHealth to improve access to affordable obesity care. This partnership fosters a model of transparent pricing merged with high-quality medical expertise, enabling employees to obtain medications without the long waits and high costs that often accompany traditional healthcare pathways.

9. Adona Medical’s Innovative Heart Failure Device


Adona Medical has completed enrollment in its first-in-human trial for a novel interatrial shunt designed for patients with heart failure. This innovative device boasts a chronically-adjustable shunt with integrated bi-atrial pressure monitoring, achieving a 100% procedural success rate across the initial cohort.

10. FDA Expanded Indication for Levita Magnetics' MARS®


The FDA has expanded the indications for Levita Magnetics' Magnetic Surgical System with MARS® technology, allowing for minimally invasive procedures in bariatric and hiatal hernia repairs. This innovative approach enhances surgical accessibility and paves the way for wider adoption across healthcare providers.

These headlines encapsulate just some of the transformative developments occurring within the health sector this week. For journalists and consumers aiming to keep pace with the latest healthcare innovations, these stories provide a valuable glimpse into future trends and methodologies. PR Newswire remains dedicated to delivering timely and relevant updates to help audiences navigate healthcare developments effectively. If you're interested in distributing your own press release, sign up with PR Newswire for unmatched reach and visibility in this dynamic industry.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.